Dear Editor, Traumatic Injuries is a serious threat to global health as more than five million people in the world are losing their lives annually making it 9% of global mortality and millions are having temporary or permanent disabilities (http://www.who.int). The biggest cause of traumatic injuries is road traffic injuries which is currently 9 largest cause of deaths globally and has been predicted to be the top fifth cause in coming decades (http://www.who.int). Low and middleincome countries (LMICs) are facing serious disabilities because of in adequate care system given in emergency departments. Recently a detailed statistical analysis and possible improvement strategies has been given regarding the care systems provided in emergency departments in LMICs which is the main reason of permanent disabilities [1, 2]. Stem cell therapy has attracted a huge attention in last few years as a promising agent in the treatment of neural damage, muscle trauma, disk degeneration, bone fusion, regeneration of craniofacial bone, spinal trauma etc [3-5]. Mesenchymal stem cells have the potential to serve as an efficient antiviral and anti-inflammatory agents against several kind of infections happened in traumatic injuries leading to disability or deaths[6]. Stem cells have also attracted attention of clinical practitioners for damaged cartilage and tendon regeneration [7, 8]. Traumatic injuries are a serious concern for health policy makers and medical practitioners on every continent regardless of LETTER
No takes yet. Share an insight, caveat, or question.
Baradranfard et al. (2015) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: